Spots Global Cancer Trial Database for Effect of Enhanced Recovery After Surgery (ERAS) on C-reactive and Visceral Proteins

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Effect of Enhanced Recovery After Surgery (ERAS) on C-reactive and Visceral Proteins

Official Title: Effect of Enhanced Recovery After Surgery (ERAS) on C-reactive and Visceral Proteins in Patients With Advanced Gastric Cancer

Study ID: NCT02348229

Conditions

Gastric Cancer

Interventions

ERAS protocols

conventional pathway group

Study Description

Brief Summary: The investigators designed a prospective randomized, controlled clinical trial then recruited 149 consecutive advanced gastric cancer patients. Further divided into a ERAS group (n=73) and a conventional pathway group (n=76). Surgical technique in both groups was same laparoscopic-assisted gastrectomy with D2 lymphadenectomy. Compared outcomes included clinical parameters and serum indicators.

Detailed Description: Enhanced recovery after surgery combined with laparoscopic-assisted gastrectomy was successfully carried out in this study. Recovery parameters such as the length of time to return to normal diet,mean hospital stay (d) were recorded.